Stem cell-derived therapeutics are redefining the frontiers of regenerative medicine, creating new approaches to tissue repair, replacement, and regeneration of damaged tissues. Progress in iPSCs, organoid technology, and tissue engineering is leading to innovations in personalized therapy, drug discovery, and disease modelling, and bringing us closer to the reality of restoring functional tissues.
At our Miami, Cell & Gene Therapy World Conference, preeminent researchers and translational experts will discuss recent advances in stem cell biology, scalable differentiation protocols, and bioengineering strategies to advance therapeutic specificity and reproducibility. The discussion also covers manufacturing standards, safety evaluations, and regulatory challenges that need to be addressed for successful clinical translation